What Is XOMA Royalty Corporation - Depo (XOMAO) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, XOMA Royalty Corporation - Depo's intrinsic value is estimated at $21.18. Trading at its current price of $25.00, the valuation engine raises significant caution: 9 of 12 models flag downside risk, projecting an average implied return of -15.3%. Notably, CUCE sees the most upside at +151.6% (fair value: $62.90), while Dynamic NAV is the most conservative at -91.1% ($2.23). The spread between these extremes — +242.7% — reveals how different analytical frameworks can reach starkly different conclusions.
What Do the Models Say About XOMAO?
12 of 13 models are currently active for XOMAO. Of these, 3 models suggest upside while 9 models suggest overvaluation. The Bayesian DCF estimates XOMAO's intrinsic value at $18.97, implying -24.1% downside from the current price. See which stocks rank higher →
How Does XOMAO Rank in Pharmaceutical Preparations?
Among 431 Pharmaceutical Preparations stocks, XOMAO ranks #89 by Quality of Company score. CirclFi's QOC score of 6.5/10 evaluates 32 fundamental signals. A score of 6.5 indicates above-average quality.
See all Most Undervalued Pharmaceutical Preparations Stocks →
The Pharmaceutical Preparations sector introduces analytical considerations specific to healthcare company businesses. For XOMA Royalty Corporation - Depo, metrics like patent cliff exposure provide important context that general-purpose valuation models may underweight.
Is XOMAO a Value Trap?
CirclFi's Value Trap algorithm assigns XOMAO a score of 32/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
12 of 13 models are active for XOMA Royalty Corporation - Depo. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Quality of Company (QOC) framework, XOMA Royalty Corporation - Depo earns a quality score of 6.5/10. This respectable rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.
The gap between the most bullish and bearish model spans +242.7% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every XOMAO valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across XOMAO's 12 active models, average confidence is 32%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad